Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7638179rdf:typepubmed:Citationlld:pubmed
pubmed-article:7638179lifeskim:mentionsumls-concept:C0035435lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C0006784lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C0054534lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:7638179lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:7638179pubmed:issue16lld:pubmed
pubmed-article:7638179pubmed:dateCreated1995-9-11lld:pubmed
pubmed-article:7638179pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:abstractTextWe identified an autoantibody that reacts with calpastatin [an inhibitor protein of the calcium-dependent neutral protease calpain (EC 3.4.22.17)]. In early immunoblot studies, sera from patients with rheumatoid arthritis (RA) recognized unidentified 60-, 45-, and 75-kDa proteins in HeLa cell extracts. To identify these autoantigens, we used patient sera to clone cDNAs from a lambda gt11 expression library. We isolated clones of four genes that expressed fusion proteins recognized by RA sera. The 1.2-kb cDNA insert (termed RA-6) appeared to encode a polypeptide corresponding to the 60-kDa antigen from HeLa cells, since antibodies bound to the RA-6 fusion protein also reacted with a 60-kDa HeLa protein. The deduced amino acid sequence of the RA-6 cDNA was completely identical with the C-terminal 178 amino acids of human calpastatin except for one amino acid substitution. Patient sera that reacted with the RA-6 also bound pig muscle calpastatin, and a monoclonal antibody to human calpastatin recognized the RA-6 fusion protein, confirming the identity of RA-6 with calpastatin. Moreover, the purified RA-6 fusion protein inhibited the proteolytic activity of calpain, and IgG from a serum containing anti-calpastatin antibodies blocked the calpastatin activity of the RA-6 fusion protein. Immunoblots of the RA-6 product detected autoantibodies to calpastatin in 57% of RA patients; this incidence was significantly higher than that observed in other systemic rheumatic diseases, including systemic lupus erythematosus (27%), polymyositis/dermatomyositis (24%), systemic sclerosis (38%), and overlap syndrome (29%). Thus, anti-calpastatin antibodies are present most frequently in patients with RA and may participate in pathogenic mechanisms of rheumatic diseases.lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:languageenglld:pubmed
pubmed-article:7638179pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:citationSubsetIMlld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7638179pubmed:statusMEDLINElld:pubmed
pubmed-article:7638179pubmed:monthAuglld:pubmed
pubmed-article:7638179pubmed:issn0027-8424lld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:SuzukiKKlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:FujiiTTlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:AkizukiMMlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:MatsumuraMMlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:YoshizawaTTlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:NojimaTTlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:MimoriTTlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:TanamiYYlld:pubmed
pubmed-article:7638179pubmed:authorpubmed-author:SuganumaKKlld:pubmed
pubmed-article:7638179pubmed:issnTypePrintlld:pubmed
pubmed-article:7638179pubmed:day1lld:pubmed
pubmed-article:7638179pubmed:volume92lld:pubmed
pubmed-article:7638179pubmed:ownerNLMlld:pubmed
pubmed-article:7638179pubmed:authorsCompleteYlld:pubmed
pubmed-article:7638179pubmed:pagination7267-71lld:pubmed
pubmed-article:7638179pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:meshHeadingpubmed-meshheading:7638179-...lld:pubmed
pubmed-article:7638179pubmed:year1995lld:pubmed
pubmed-article:7638179pubmed:articleTitleAutoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.lld:pubmed
pubmed-article:7638179pubmed:affiliationDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.lld:pubmed
pubmed-article:7638179pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7638179pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7638179pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:831entrezgene:pubmedpubmed-article:7638179lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7638179lld:pubmed
More...